Clinical Trial Update: PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER) [NA]

View source ↗

Summary

Clinical trial update on PSMA MRI-guided prostate SBRT with longitudinal imaging biomarker assessments after radiotherapy in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING